Portola Pharmaceuticals Inc. (PTLA) announced around mid-afternoon Friday that the FDA has accepted its New Drug Application granting priority review for betrixaban. The company also announced that the European Medicines Agency has validated its Marketing Authorization Application for betrixaban.
from RTT - Before the Bell http://ift.tt/2iactA2
via IFTTT
No comments:
Post a Comment